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We constructed a chimeric cDNA clone of hepatitis C virus (HCV) that is infectious. The chimeric genome encodes the
polyprotein of a genotype 1b strain (HC-J4) of HCV and replicates via 59 and 39 untranslated regions of a genotype 1a strain.
The infectivity of three full-length cDNA clones was tested by direct injection of RNA transcripts into the liver of a
chimpanzee. The chimpanzee became infected with HCV and the viral titer increased over time from 102 genome equivalents
(GE)/ml at week 1 postinoculation (p.i.) to 104–105 GE/ml during weeks 3–11 p.i. Antibodies to HCV were detected from week
18 p.i. However, the chimpanzee did not develop hepatitis. Sequence analysis of PCR products amplified from the serum of
the chimpanzee demonstrated that only one of the three clones was infectious. Sequence comparisons with the cloning
source, an acute-phase infectious plasma pool derived from an experimentally infected chimpanzee, showed that this
infectious clone had three amino acids that differed from the consensus sequence of HC-J4, whereas the two noninfectious
clones had seven and nine amino acid differences, respectively. Together, genotype 1b, represented by the infectious
molecular clone described herein, and genotype 1a, represented by the two cDNA clones previously shown to be infectious
for chimpanzees, account for the majority of HCV infections in the United States, Europe, and Japan. © 1998 Academic Press
INTRODUCTION
Hepatitis C virus (HCV) is a major cause of chronic
liver disease (Houghton, 1996). More than 80% of indi-
viduals infected with HCV become chronically infected,
with about 4 million people infected in the United States
(Alter, 1997; Hoofnagle, 1997). Chronically infected indi-
viduals have a relatively high risk of developing chronic
hepatitis, liver cirrhosis, and hepatocellular carcinoma
(Hoofnagle, 1997). The only effective therapy for chronic
hepatitis C, interferon (IFN), induces a sustained re-
sponse in less than 25% of treated patients (Fried and
Hoofnagle, 1995). Consequently, HCV is currently the
most common cause of end-stage liver failure and the
reason for about 30% of liver transplants performed in the
United States (Hoofnagle, 1997). There is no vaccine for
HCV. Although the number of acute HCV infections has
declined, in part because of effective screening of blood
and blood products, it is estimated that there are still
more than 25,000 new infections yearly in the United
States (Alter, 1997). Thus, HCV constitutes a serious
public health problem.
Hepatitis C virus has a positive-sense single-strand
RNA genome and is a member of the virus family Flavi-
viridae (Choo et al., 1991; Rice, 1996). The viral genome of
approximately 9600 nucleotides (nt) consists of a highly
conserved 59 untranslated region (UTR), a single long
open reading frame (ORF) of approximately 9000 nt, and
a complex 39 UTR. The 59 UTR contains an internal
ribosomal entry site (Tsukiyama-Kohara et al., 1992;
Honda et al., 1996). The 39 UTR consists of a short
variable region, a polypyrimidine tract of variable length,
and, at the 39 end, a highly conserved region of approx-
imately 100 nt (Kolykhalov et al., 1996; Tanaka et al., 1995,
1996; Yamada et al., 1996). The last 46 nucleotides of this
conserved region were predicted to form a stable stem-
loop structure thought to be critical for viral replication
(Blight and Rice, 1997; Ito and Lai, 1997; Tsuchihara et al.,
1997). The ORF encodes a large polyprotein precursor
that is cleaved into at least 10 proteins by host and viral
proteinases (Rice, 1996). The predicted envelope pro-
teins contain several conserved N-linked glycosylation
sites and cysteine residues (Okamoto et al., 1992a). The
NS3 gene encodes a serine proteinase and an RNA
helicase and the NS5B gene encodes an RNA-depen-
dent RNA polymerase.
Globally, six major HCV genotypes (genotypes 1–6)
and multiple subtypes (a, b, c, etc.) have been identified
(Bukh et al., 1993; Simmonds et al., 1993). The most
divergent HCV isolates differ from each other by more
than 30% over the entire genome (Okamoto et al., 1992a).
Infection with genotype 1 is most prevalent (Bukh et al.,
1995). In the United States, HCV genotypes 1a and 1b
constitute the majority of infections. In many other areas,
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especially in Europe and Japan, genotype 1b predomi-
nates. Recently, a number of studies have suggested that
the severity of liver disease and the outcome of therapy
may be genotype-dependent (reviewed in Bukh et al.,
1997). In these studies infection with HCV genotype 1b
was associated with more severe liver disease (Brechot,
1997) and a poorer response to IFN therapy (Fried and
Hoofnagle, 1995). However, the exact biological conse-
quences of the genetic heterogeneity of HCV are still
unclear.
HCV circulates in an infected individual as a quasi-
species of closely related genomes (Bukh et al., 1995;
Farci et al., 1997). The genetic heterogeneity of HCV is
not distributed uniformly throughout the genome but is
concentrated in hypervariable region 1 (HVR1) at the
amino-terminal end of E2 (Weiner et al., 1991; Hijikata et
al., 1991). The HVR1 region contains a neutralization
epitope (Farci et al., 1996; Shimizu et al., 1996) and the
amino acid sequence of HVR1 can undergo sequential
changes during infection, probably resulting in escape
from immune surveillance by the host and establishment
of persistent HCV infection (Weiner et al., 1992; Farci et
al., 1997). A second hypervariable region was identified
in E2 (HVR2) but only in genotype 1b strains of HCV
(Hijikata et al., 1991). The quasispecies nature of HCV
might also impact the severity of associated liver disease
and resistance to IFN treatment (reviewed in Farci et al.,
1997).
Hepatitis C virus infects some continuous human T
cell lines in vitro (Shimizu et al., 1992) but replicates
poorly in such cell cultures. The chimpanzee is the
only nonhuman host of HCV (Farci et al., 1993), but its
availability is very limited. This lack of a convenient
animal model or an efficient in vitro propagation sys-
tem has made it difficult to study the virological char-
acteristics of HCV or to develop antiviral therapies and
vaccines.
Recently, two research groups independently con-
structed an infectious cDNA clone of strain H77 (geno-
type 1a) of HCV (Kolykhalov et al., 1997; Yanagi et al.,
1997). In both studies, RNA transcripts encoding the
consensus amino acid sequence of the putative polypro-
tein were infectious for chimpanzees, whereas those
encoding a nonconsensus polyprotein were not. These
infectious clones should aid in studying HCV replication
and pathogenesis and should provide an important tool
for development of in vitro replication and propagation
systems. However, given the extensive genetic hetero-
geneity of HCV, it will probably be important to have
infectious clones of more than one genotype. Although
the near-complete genomic sequences of several HCV
strains have been published, past experience suggests
that it will be difficult to clone the infectious sequence.
First, the viral quasispecies possibly include a proportion
of defective or noninfectious genomes. Second, clinical
samples obtained from patients or experimentally in-
fected chimpanzees contain only minute amounts of viral
RNA. Therefore, it is necessary to perform in vitro ampli-
fication of viral RNA by reverse transcription (RT) and
PCR, which can introduce errors into the cDNA derived
from the viral genomes.
In the present study, we performed a detailed se-
quence analysis of the HC-J4 strain of genotype 1b
that had been biologically amplified in a chimpanzee
and constructed an infectious chimeric cDNA clone by
inserting the complete ORF of the genotype 1b strain
into a cassette vector that incorporated part of the
untranslated regions of an infectious clone of a geno-
type 1a strain.
RESULTS
Quasispecies of strain HC-J4 in the infectious plasma
pool used as the cloning source
An infectious cDNA clone of a genotype 1a strain of
HCV had been obtained only after the ORF was engi-
neered to encode the consensus polyprotein (Kolykha-
lov et al., 1997; Yanagi et al., 1997). Thus, prior to
constructing an infectious cDNA clone of a 1b geno-
type, we performed a detailed sequence analysis of
the cloning source to determine the consensus se-
quence. A plasma pool of strain HC-J4 was prepared
from acute-phase plasmapheresis units collected from
a chimpanzee experimentally infected with HC-J4/91
(Okamoto et al., 1992b). This HCV pool had a PCR titer
of 104–105 GE/ml and an infectivity titer of approxi-
mately 103 chimpanzee infectious doses/ml (Bukh et
al., unpublished data).
We determined the heterogeneity of the 39 UTR of
strain HC-J4 by analyzing 24 clones of nested RT–PCR
product. The consensus sequence was identical to
that previously published for HC-J4/91 (Okamoto et al.,
1992b), except at position 9407 (see below). The vari-
able region consisted of 41 nucleotides (nt 9372–9412),
including two in-frame termination codons. Further-
more, its sequence was highly conserved except at
positions 9399 (19 A and 5 T clones) and 9407 (17 T
and 7 A clones). The poly(U-UC) region varied slightly
in composition and greatly in length (31–162 nucleo-
tides). In the conserved region, the first 16 nucleotides
of 22 clones were identical to those previously pub-
lished for other genotype 1 strains, whereas 2 clones
each had a single point mutation. These data sug-
gested that the structural organization at the 39 end of
HC-J4 was similar to that of our infectious clone of a
genotype 1a strain.
We next amplified the entire ORF of HC-J4 in a single
round of long RT-PCR (Fig. 1). Our original plan was to
clone the resulting PCR products into the PinAI and Brf I
site of a HCV cassette vector (pCV), which had fixed 59
and 39 termini of genotype 1a (Yanagi et al., 1997). How-
ever, we were not able to obtain full-length clones. There-
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fore, we separately subcloned into pCV two genome
fragments (L and S) derived from the long RT–PCR prod-
ucts (Fig. 2).
To determine the consensus sequence of the ORF we
sequenced nine clones each of the L fragment (pCV-J4L)
and of the S fragment (pCV-J4S). We found a quasispe-
cies at 275 nucleotide (3.05%) and 78 amino acid (2.59%)
positions, scattered throughout the 9030 nt (3010 aa) of
the ORF (Fig. 3). Of the 161 nucleotide substitutions
unique to a single clone, 71% were at the third position of
the codon and 72% were silent.
Each of the nine L clones represented the near-com-
plete ORF of an individual genome. The differences
among the L clones were 0.30–1.53% at the nucleotide
and 0.31–1.47% at the amino acid level (Fig. 4). Two
clones, L1 and L7, had a defective ORF due to a single
nucleotide deletion and a single nucleotide insertion,
respectively. Even though the HC-J4 plasma pool was
obtained in the early acute phase, it appeared to contain
at least three viral species (Fig. 5). Species A contained
the L1, L2, L6, L8, and L9 clones, species B the L3, L7,
and L10 clones, and species C the L4 clone. Although
each species A clone was unique, all A clones differed
from all B clones at the same 20 amino acid sites (Fig. 3).
At these positions, species C had the species A se-
quence at 14 positions and the species B sequence at 6
positions (Fig. 3).
Okamoto and co-workers (Okamoto et al., 1992b) pre-
viously determined the nearly complete genome consen-
sus sequence of strain HC-J4 in acute-phase serum of
the first chimpanzee passage (HC-J4/83) as well as in
chronic-phase serum collected 8.2 years later (HC-J4/91).
In addition, they determined the sequence of amino ac-
ids 379 to 413 (including HVR1) and amino acids 468 to
486 (including HVR2) of multiple individual clones (Oka-
moto et al., 1992b). We found that the sequences of
individual genomes in the plasma pool collected from a
chimpanzee inoculated with HC-J4/91 were all more
closely related to HC-J4/91 than to HC-J4/83 (Figs. 4 and
5) and contained HVR amino acid sequences closely
related to three of the four viral species previously found
in HC-J4/91 (Fig. 6).
The difficulty of determining the consensus sequence
of HC-J4 in the plasma pool
We determined the consensus sequence of nucleo-
tides 156–9371 of HC-J4 by two approaches. In one
approach, the consensus sequence was deduced from
nine clones of the long RT–PCR product. In the other
approach the long RT–PCR product was reamplified by
PCR as overlapping fragments which were sequenced
directly. The two ‘‘consensus’’ sequences differed at 31
(0.34%) of 9216 nucleotide positions and at 11 (0.37%) of
3010 deduced amino acid positions (Fig. 3). At all of
these positions a major quasispecies of strain HC-J4
was found in the plasma pool. At 9 additional amino acid
positions the cloned sequences displayed heterogeneity
and the direct sequence was ambiguous (Fig. 3). Finally,
it should be noted that there were multiple amino acid
positions at which the consensus sequence obtained by
direct sequencing was identical to that obtained by clon-
ing and sequencing even though a major quaisispecies
was detected (Fig. 3).
For positions at which the two ‘‘consensus’’ sequences
of HC-J4 differed, we included both amino acids in a
composite consensus sequence (Fig. 3). However, even
with this allowance, none of the nine L clones analyzed
(aa 1–2864) had the composite consensus sequence:
two clones did not encode the complete polyprotein and
the remaining seven clones differed from the consensus
sequence by 3–13 amino acids (Fig. 3).
Chimeric full-length cDNA clones containing the
entire ORF of HC-J4
Three full-length cDNA clones were constructed by
cloning different L fragments into the PinAI/BglII site of
pCV-J4S9, the cassette vector for genotype 1a (Fig. 2),
which also contained an S fragment encoding the con-
sensus amino acid sequence of HC-J4. Therefore, al-
though the ORF was from strain HC-J4, most of the 59 and
39 terminal sequence originated from strain H77 (Yanagi
et al., 1997). As a result, the 59 and 39 UTR were chimeras
of genotypes 1a and 1b (Fig. 7). The first 155 nucleotides
of the 59 UTR were from strain H77 (genotype 1a) and
differed from the authentic sequence of HC-J4 (genotype
1b) at nucleotides 11, 12, 13, 34, and 35. In two clones
(pCV-J4L2S, pCV-J4L6S) the rest of the 59 UTR had the
consensus sequence of HC-J4, whereas the third clone
(pCV-J4L4S) had a single nucleotide insertion at position
207. In all three clones the first 27 nucleotides of the 39
variable region of the 39 UTR were identical with the
consensus sequence of HC-J4. The remaining 15 nucle-
otides of the variable region, the poly(U-UC) region, and
the 39 conserved region of the 39 UTR had the same
FIG. 1. Agarose gel of long RT–PCR amplicons and transcription
mixtures. Lanes 1 and 4: Molecular weight marker (l/HindIII digest).
Lanes 2 and 3: RT–PCR amplicons of the entire ORF of HC-J4. Lane 5:
pCV-H77C transcription control (Yanagi et al., 1997). Lanes 6–8: 1/40 of
each transcription mixture of pCV-J4L2S, pCV-J4L4S, and pCV-J4L6S,
respectively, which was injected into the chimpanzee.
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sequence as an infectious clone of strain H77 (Yanagi et
al., 1997).
None of the three full-length clones of HC-J4 had the
ORF composite consensus sequence (Figs. 3 and 8). The
pCV-J4L6S clone had only three amino acid changes: Q
for R at position 231 (E1), V for A at position 937 (NS2),
and T for S at position 1215 (NS3). The pCV-J4L4S clone
had seven amino acid changes, including a change at
position 450 (E2) that eliminated a highly conserved
N-linked glycosylation site (Okamoto et al., 1992a). Fi-
nally, the pCV-J4L2S clone had nine amino acid changes
compared with the consensus sequence of HC-J4. A
change at position 304 (E1) mutated a highly conserved
cysteine residue (Bukh et al., 1993; Okamoto et al.,
1992a).
Transfection of a chimpanzee by transcripts from a
chimeric cDNA clone
We tested the infectivity of RNA transcripts from the
three chimeric cDNA clones simultaneously in a chim-
panzee. The chimpanzee became infected with HCV as
measured by increasing titers of 102 GE/ml at week 1 p.i.,
103 GE/ml at week 2 p.i., and 104–105 GE/ml during
weeks 3 to 11 p.i. (Fig. 9). The chimpanzee was negative
for HCV RNA at weeks 19 and 20 p.i. (see Note added in
FIG. 2. Strategy for the construction of full-length cDNA clones of HCV strain HC-J4. The long PCR products were cloned as two separate fragments
(L and S) into a cassette vector (pCV) with fixed 59 and 39 termini of HCV (Yanagi et al., 1997). Full-length cDNA clones of HC-J4 were obtained by
inserting the L fragment from three pCV-J4L clones into three identical pCV-J4S9 clones after digestion with PinAI (isoschizomer of AgeI) and BglII.
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FIG. 3. Amino acid positions with a quasispecies of HC-J4 in the acute-phase plasma pool obtained from an experimentally infected chimpanzee.
Cons-p9: consensus amino acid sequence deduced from analysis of nine L fragments and nine S fragments (see Fig. 2). Cons-D: consensus
sequence derived from direct sequencing of the PCR product. A–C: groups of similar viral species. Dot: amino acid identical to that in Cons-p9. Capital
letter: amino acid different from that in Cons-p9. Cons-F: composite consensus amino acid sequence combining Cons-p9 and Cons-D. Boxed amino
acid: different from that in Cons-F. Shaded amino acid: different from that in all species A sequences. An asterisk indicates defective ORF due to a
nucleotide deletion (clone L1, aa 1097) or insertion (clone L7, aa 2770). Diagonal lines: fragments used to construct the infectious clone.
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proof) and antibodies to HCV were detected (weeks
18–20 p.i.). Serum liver enzyme levels were within normal
range throughout follow-up.
To identify which of the three full-length HC-J4 clones
were infectious, we cloned and sequenced the NS3
region (nt 3659–4110) of HCV genomes amplified by
RT–PCR from serum samples taken from the infected
chimpanzee during weeks 2 and 4 p.i. The PCR primers
were a complete match with each of the original three
clones. Thus, this assay should not have preferentially
amplified one virus over another. Sequence analysis of
26 and 24 clones obtained at weeks 2 and 4 p.i., respec-
tively, demonstrated that all originated from the tran-
scripts of pCV-J4L6S. The consensus sequence of PCR
products of the nearly complete genome (nt 11–9441),
amplified from serum obtained during week 2 p.i., was
identical to the sequence of pCV-J4L6S and there was no
evidence of quasispecies. Thus, RNA transcripts of pCV-
J4L6S, but not of pCV-J4L2S or pCV-J4L4S, were infec-
tious in vivo.
The chimeric sequences of genotypes 1a and 1b in the
UTRs were maintained in the infected chimpanzee. The
consensus sequence of nucleotides 11–341 of the 59
UTR and the variable region of the 39 UTR, amplified from
serum obtained during weeks 2 and 4 p.i., had the ex-
pected chimeric sequence of genotypes 1a and 1b (Fig.
7). Also, three of four clones of the 39 UTR obtained at
week 2 p.i. had the chimeric sequence of the variable
FIG. 4. Comparisons (percent difference) of nucleotide (nt 156–8935) and predicted amino acid sequences (aa 1–2864) of L clones (species A–C,
this study), HC-J4/91 (Okamoto et al., 1992b), and HC-J4/83 (Okamoto et al., 1992b). Differences among species A sequences and among species B
sequences are shaded.
FIG. 5. UPGMA trees of HC-J4/91 (Okamoto et al., 1992b), HC-J4/83 (Okamoto et al., 1992b), two prototype strains of genotype 1b (HCV-J, Kato et
al., 1990; HCV-BK, Takamizawa et al., 1991), and L clones (this study).
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region, whereas a single substitution was noted in the
fourth clone. However, in all four clones the poly(U)
region was longer (2–12 nt) than expected. Also, we
observed extra C and G residues in this region. For the
most part, the number of C residues in the poly(UC)
region was maintained in all clones, although the spac-
ing varied. As we showed previously, variations in the
number of U residues can reflect artifacts introduced
during PCR amplification (Yanagi et al., 1997). The se-
quence of the first 19 nucleotides of the conserved re-
gion was maintained in all four clones. Thus, with the
exception of the poly(U-UC) region, the genomic se-
quences recovered from the infected chimpanzee were
exactly those of the chimeric infectious clone.
DISCUSSION
After much effort, the first cDNA clones of HCV that are
infectious for chimpanzees were recently constructed
(Kolykhalov et al., 1997; Yanagi et al., 1997). Both of these
previously reported clones were derived from strain H77,
which is genotype 1a. We used the cassette vector we
developed to clone strain H77 to construct an infectious
cDNA clone containing the ORF of a second subtype.
This new clone contains a chimeric HCV genome, which
is composed mostly of genotype 1b sequences from
strain HC-J4. The encoded polyproteins of genotypes 1a
and 1b share only about 85% identity. Genotype 1b is the
most prevalent genotype of HCV in the United States,
Europe, and Japan. The availability of infectious clones
representing two important subtypes of genotype 1
should provide new ways of studying this virus.
There is no effective in vitro propagation or replication
system for HCV. Thus, the infectivity of HCV clones has
been determined by in vivo transfection: viral nucleic
acid is injected directly into the liver of a chimpanzee.
The previous transfection protocols had required lapa-
rotomy (Kolykhalov et al., 1997; Yanagi et al., 1997), which
can be performed only once per animal. In the present
study, we demonstrated that the in vivo transfection
could be performed by ultrasound-guided percutaneous
intrahepatic injection (St. Claire et al., unpublished data).
This less invasive procedure should facilitate in vivo
studies of cDNA clones of HCV in chimpanzees, since
percutaneous procedures can be performed repeatedly.
We demonstrated that RNA transcripts of one cDNA
clone of HC-J4, but not of two other clones with different
ORFs but the same termini, were infectious in vivo. We
injected the same amount of cDNA and transcription
mixture for each of the clones (Fig. 1) so the failures to
infect were not due to insufficient RNA. In the previous
two reports on infection of chimpanzees only those
clones engineered to have the independently deter-
mined and slightly different consensus amino acid se-
quence of the polyprotein of strain H77 were infectious
(Kolykhalov et al., 1997; Yanagi et al., 1997). Although the
two infectious clones differed at 4 amino acid positions,
these differences were represented in a major compo-
nent of the quasispecies of the cloning source (Yanagi et
FIG. 6. Alignment of the HVR1 and HVR2 amino acid sequences of the E2 of HCV. The sequences of nine L clones of HC-J4 (species A–C) obtained
from an early acute-phase plasma pool of an experimentally infected chimpanzee were compared with the sequences of eight clones (HC-J4/91-20
through HC-J4/91-27, Okamoto et al., 1992b) derived from the inoculum. Dot: an amino acid identical to that in the top line. Capital letters: amino acid
different from that in the top line.
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al., unpublished data) and therefore did not represent
substantial differences. In the present study, we were
unable to define a single consensus sequence of strain
HC-J4, because the consensus sequence obtained by
two different approaches (direct sequencing and se-
quencing of cloned products) differed at 20 amino acid
positions, even though the same genomic PCR product
was analyzed. The infectious clone differed at 2 positions
from the composite amino acid consensus sequence,
from the sequence of the eight additional HC-J4 clones
analyzed in this study and from published sequences of
earlier passage samples. An additional amino acid dif-
fered from the composite consensus sequence but was
found in two other HC-J4 clones analyzed in this study.
The two noninfectious full-length clones of HC-J4 differed
from the composite consensus sequence by only 7 and
FIG. 7. Alignment of the 59 and the 39 UTR sequences of infectious clones of genotype 1a (pCV-H77C) and 1b (pCV-J4L6S). Top line: consensus
sequence of the indicated strain. Dot: identity with consensus sequence. Capital letter: different from the consensus sequence. Dash: deletion.
Underlined: PinAI and BfrI cleavage site. Numbering corresponds to the HCV sequence of pCV-J4L6S.
FIG. 8. Comparison of the ORF of individual full-length cDNA clones of HCV strain HC-J4 with the consensus sequence (see Fig. 3). Solid lines:
amino acid changes. Dashed lines: silent mutations. Clone pCV-J4L6S was infectious in vivo, whereas clones pCV-J4L2S and pCV-J4L4S were not.
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9 amino acid differences. However, since these clones
had the same termini as the infectious clone (except for
a single nucleotide insertion in the 59 UTR of pCV-J4L4S),
one or more of these amino acid changes in each clone
was apparently deleterious for the virus. Although we
have formally demonstrated for the first time that HCV
polyprotein sequences other than the consensus se-
quence can be infectious, our data confirmed that devi-
ations from the consensus sequence are often lethal.
The genome termini must interact with the viral poly-
merase during initiation of viral replication. Since the
amino acid sequence of the putative RNA-dependent
RNA polymerases of HC-J4 and H77 varied by more than
10% it was not obvious that the polymerase of HC-J4
would be able to replicate a chimeric genome containing
portions of the H77 termini. The 59 UTR sequence of the
infectious genotype 1b clone differed from the sequence
of the original genotype 1b virus at 5 nucleotide posi-
tions, all close to the 59 end where they might be ex-
pected to affect RNA replication. In the 39 UTR of this
infectious clone, the 39 variable sequence was chimeric
and represented strain H77 rather than strain HC-J4 in 5
of 42 positions. Thus, although the 39 variable sequence
was highly conserved within HC-J4, this strain-specific
sequence was not critical for replication by the HC-J4
polymerase. In the present study, we found that HC-J4,
like other strains of genotype 1b (Kolykhalov et al., 1996;
Tanaka et al., 1996; Yamada et al., 1996), had a poly(U-
UC) region followed by a terminal conserved element.
The poly(U-UC) region appears to vary considerably, so it
was not clear whether changes in this region would have
a significant effect on virus replication. On the other
hand, the 39 98 nucleotides of the HCV genome were
previously shown to be identical among other strains of
genotypes 1a and 1b (Kolykhalov et al., 1996; Tanaka et
al., 1996). Thus, use of the cassette vector would not alter
this region except for addition of 3 nucleotides found in
strain H77 between the poly(UC) region and the 39 98
conserved nucleotides. This study showed for the first
time that it is possible to make infectious viruses con-
taining terminal sequences specific for two different sub-
types of the same major genotype of HCV.
The viremic pattern found in the early phase of the
infection with the recombinant HC-J4 virus was similar to
that observed for the recombinant H77 virus in chimpan-
zees (Bukh et al., unpublished data; Kolykhalov et al.,
1997; Yanagi et al., 1997). Two chimpanzees infected with
the recombinant H77 virus developed hepatitis (Bukh et
al., unpublished data), whereas the chimpanzee infected
with the recombinant HC-J4 virus in the present study
had no biochemical evidence of hepatitis. It is well
known that biological variation exists and some chim-
panzees inoculated with HCV either lack or develop
minimal evidence of hepatitis even though the same
inoculum caused disease in other animals. Thus, the
phenotype of the infectious clone of strain HC-J4 can be
determined only by transfection of several chimpanzees.
The chimpanzee transfected in the present study was
chronically infected with hepatitis G virus (HGV/GBV-C)
(Bukh et al., 1998) and had a titer of 106 GE/ml at the time
of HCV transfection. Although HGV/GBV-C was originally
believed to be a hepatitis virus, it does not cause hepa-
titis in chimpanzees (Bukh et al., 1998) and may not
replicate in the liver (Laskus et al., 1997). Our study
demonstrated that an ongoing infection of HGV/GBV-C
did not prevent acute HCV infection in the chimpanzee
model.
In two previous studies it was reported that RNA tran-
scripts from cDNA clones of HCV-1 (genotype 1a) and
HCV-N (genotype 1b), respectively, resulted in viral rep-
lication after transfection into human hepatoma cell lines
(Dash et al., 1997; Yoo et al., 1995). In both of these
studies, infectivity was reported for clones that did not
contain the terminal 98 conserved nucleotides at the
very 39 end of the 39 UTR. The viability of these clones
was not tested in vivo and concerns were raised about
the infectivity of these cDNA clones in vitro (Fausto,
1997). With the chimpanzee transfection system we have
developed, we have begun to test directly the require-
ment for this region in a biologically relevant way.
Since the nearly complete ORF was amplified in long
RT–PCR and cloned in one step, we were able to study
the quasispecies nature of the cloning source as re-
flected by colinear mutations throughout the HCV ge-
nome. Our analysis showed that the quasispecies of
HC-J4 found in this acute-phase pool represented at
least three viral species and that a quasispecies in the
HVR1 region of HCV paralleled quasispecies at multiple
other positions throughout the genome. It was previously
demonstrated that each chimpanzee inoculated with an
acute-phase plasma pool of patient H (H77) became
infected with a different dominant sequence (Farci et al.,
FIG. 9. Course of infection with hepatitis C virus (HCV) in chimpanzee
1500 following transfection with the infectious cDNA clone pCV-J4L6S
(strain HC-J4, genotype 1b). Results of qualitative RT-nested PCR for
HCV RNA (filled rectangles, positive; empty rectangles, negative) and
second-generation ELISA test for anti-HCV [(1) positive; (2) negative]
are shown. Serum levels of alanine aminotransferase (ALT; shaded
area) and the log10 HCV genome equivalent titer (vertical columns) are
plotted against time.
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1994), indicating that multiple components of a quasi-
species were infectious. Our findings in the present study
indicate that simultaneous transmission of multiple spe-
cies to a single chimpanzee occurred. The quasispecies
of HC-J4 found in the acute-phase pool represented
three of the four major quasispecies found in the inocu-
lum (HC-J4/91, Okamoto et al., 1992b). Our observation
clearly illustrates the difficulties in accurately determin-
ing the evolution of HCV over time since multiple species
with significant changes throughout the HCV genome
can be present from the onset of the infection. Infection
of chimpanzees with monoclonal viruses derived from
the infectious clones should make it possible to perform
more detailed studies of the evolution of HCV in vivo and
its importance for viral persistence and pathogenesis.
In conclusion, we have constructed an infectious
clone representing a genotype 1b strain of HCV. Our
study demonstrated that it was possible to obtain an
infectious clone of a second strain of HCV, that a con-
sensus amino acid sequence was not absolutely re-
quired for infectivity, and that chimeras between the
UTRs of two different genotypes could be viable. The
availability of an infectious clone of a second strain of
HCV, representing the most prevalent genotype in the
world, should be important for further studies of viral
replication and pathogenesis of HCV and should permit
more detailed studies of the function of HCV proteins.
MATERIALS AND METHODS
Source of HCV genotype 1b
An infectious plasma pool (second chimpanzee pas-
sage) containing strain HC-J4, genotype 1b, was pre-
pared from acute phase plasma of a chimpanzee exper-
imentally infected with serum containing HC-J4/91 (Oka-
moto et al., 1992b). The HC-J4/91 sample was obtained
from a first chimpanzee passage during the chronic
phase of hepatitis C about 8 years after experimental
infection. The consensus sequence of the entire ge-
nome, except for the very 39 end, was determined previ-
ously for HC-J4/91 (Okamoto et al., 1992b).
Preparation of HCV RNA
Viral RNA was extracted from 100-ml aliquots of the
HC-J4 plasma pool with the TRIzol system (GIBCO BRL).
The RNA pellets were each resuspended in 10 ml of 10
mM dithiothreitol (DTT) with 5% (vol/vol) RNasin (20–40
units/ml) (Promega) and stored at 280°C or immediately
used for cDNA synthesis.
Amplification and cloning of the 39 UTR
A region spanning from NS5B to the conserved region
of the 39 UTR was amplified in nested RT–PCR (Yanagi et
al., 1997). The RNA was denatured at 65°C for 2 min, and
cDNA was synthesized at 42°C for 1 h with Superscript
II reverse transcriptase (GIBCO BRL) and primer
H39X58R (Yanagi et al., 1997) in a 20-ml reaction volume.
The cDNA mixture was treated with RNase H and RNase
T1 (GIBCO BRL) at 37°C for 20 min. The first round of
PCR was performed on 2 ml of the final cDNA mixture in
a total volume of 50 ml with the Advantage cDNA poly-
merase mix (Clontech) and external primers H9261F and
H39X58R (Yanagi et al., 1997). In the second round of PCR
[internal primers H9282F and H39X45R (Yanagi et al.,
1997)], 5 ml of the first round PCR mixture was added to
45 ml of the PCR reaction mixture. Each round of PCR (35
cycles) was performed in a DNA thermal cycler 480
(Perkin–Elmer) and consisted of denaturation at 94°C for
1 min (first cycle: 1 min 30 s), annealing at 60°C for 1 min,
and elongation at 68°C for 2 min. After purification with
QIAquick PCR purification kit (QIAGEN), digestion with
HindIII and XbaI (Promega), and phenol/chloroform ex-
traction, the amplified products were cloned into pGEM-
9zf(2) (Promega) (Yanagi et al., 1997).
Amplification and cloning of the entire ORF
A region from within the 59 UTR to the variable region
of the 39 UTR of strain HC-J4 was amplified by long
RT–PCR (Fig. 1) (Yanagi et al., 1997). The cDNA was
synthesized at 42°C for 1 h in a 20-ml reaction volume
with Superscript II reverse transcriptase and primer J4-
9405R (59-GCCTATTGGCCTGGAGTGGTTAGCTC-39) and
treated with RNases as above. The cDNA mixture (2 ml)
was amplified by long PCR with the Advantage cDNA
polymerase mix and primers A1 (Bukh et al., 1992; Yanagi
et al., 1997) and J4-9398R (59-AGGATGGCCTTAAGGCCT-
GGAGTGGTTAGCTCCCCGTTCA-39). Primer J4-9398R
contained extra bases (italics) and an artificial AflII cleav-
age site (underlined). A single PCR round was performed
in a Robocycler thermal cycler (Stratagene) and con-
sisted of denaturation at 99°C for 35 s, annealing at 67°C
for 30 s, and elongation at 68°C for 10 min during the first
5 cycles, 11 min during the next 10 cycles, 12 min during
the following 10 cycles, and 13 min during the last 10
cycles.
After we digested the long PCR products obtained
from strain HC-J4 with PinAI (isoschizomer of AgeI) and
BfrI (isoschizomer of AflII) (Boehringer Mannheim), we
attempted to clone them directly into a cassette vector
(pCV), which contained the 59 and 39 termini of strain H77
(Yanagi et al., 1997). However, we did not obtain any
full-length clones. To improve the efficiency of cloning,
we further digested the PCR product with BglII (Boehr-
inger Mannheim) and cloned the two resultant genome
fragments (L fragment: PinAI/BglII, nt 156–8935; S frag-
ment: BglII/BrfI, nt 8936–9398) separately into pCV (Fig.
2). DH5a-competent cells (GIBCO BRL) were trans-
formed and selected on LB agar plates containing 100
mg/ml ampicillin (SIGMA) and amplified in LB liquid cul-
tures at 30°C for 18–20 h. Sequence analysis of nine
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plasmids containing the S fragment (miniprep samples)
and nine plasmids containing the L fragment (maxiprep
samples) were performed as described previously
(Yanagi et al., 1997).
Three L fragments, each encoding a distinct polypro-
tein, were cloned into pCV-J4S9, which contained an S
fragment encoding the consensus amino acid sequence
of HC-J4, to construct three chimeric full-length HCV
cDNAs (pCV-J4L2S, pCV-J4L4S, and pCV-J4L6S) (Fig. 2).
Large-scale preparation of each clone was performed as
described previously (Yanagi et al., 1997) and the authen-
ticity of each clone was confirmed by sequence analysis.
Sequence analysis
Both strands of DNA were sequenced with the ABI
PRISM Dye Termination Cycle Sequencing Ready Reac-
tion Kit using Taq DNA polymerase (Perkin–Elmer) and
about 90 specific sense and antisense primers. Analyses
of genomic sequences, including multiple sequence
alignments and tree analyses, were performed with
GeneWorks (Oxford Molecular Group) (Bukh et al., 1995).
We determined the consensus sequence of strain
HC-J4 by direct sequencing of PCR products (nt 11–9412)
and by sequence analysis of multiple cloned L and S
fragments (nt 156–9371). The consensus sequence of the
39 UTR (the 39 variable region, the polypyrimidine tract,
and the first 16 nt of the conserved region) was deter-
mined by analysis of 24 cDNA clones.
Intrahepatic transfection of a chimpanzee with
transcribed RNA
Two in vitro transcription reactions were performed
with each of the three full-length clones. In each reaction
10 mg of plasmid DNA linearized with XbaI (Promega)
was transcribed in a 100-ml reaction volume with T7 RNA
polymerase (Promega) at 37°C for 2 h as described
previously (Yanagi et al., 1997). Five microliters of the
final reaction mixture was analyzed by agarose gel elec-
trophoresis and ethidium bromide staining (Fig. 1). Each
transcription mixture was diluted with 400 ml of ice-cold
phosphate-buffered saline without calcium or magne-
sium and then the two aliquots from the same cDNA
clone were combined, immediately frozen on dry ice, and
stored at 280°C. Within 24 h after freezing the transcrip-
tion mixtures were injected into the chimpanzee by per-
cutaneous intrahepatic injection that was guided by ul-
trasound. Each inoculum was individually injected (five
or six sites) into a separate area of the liver to prevent
complementation or recombination. The chimpanzee
was maintained under conditions that met all require-
ments for its use in an approved facility.
Serum samples were collected weekly from the chim-
panzee and monitored for liver enzyme levels [alanine
aminotransferase (ALT), gammaglutamyltranspeptidase
(GGT), and isocitrate dehydrogenase (ICD)] and anti-HCV
antibodies [second-generation ELISA test (Abbott)].
Weekly samples of 100 ml of serum were tested for HCV
RNA in a sensitive nested RT–PCR assay (Bukh et al.,
1992, Yanagi et al., 1996) with AmpliTaq Gold DNA poly-
merase. The genome equivalent (GE) titer of HCV was
determined by testing 10-fold serial dilutions of the ex-
tracted RNA in the RT–PCR assay (Yanagi et al., 1996).
We defined one GE as the number of HCV genomes
present in the highest dilution positive in the RT-nested
PCR assay. Duplicate titers determined by the ‘‘Amplicor
HCV Monitor Test’’ (Roche Diagnostic Systems) (data not
shown) were equivalent to these except at weeks 2, 17,
and 18 p.i., where the titers were below the detection
limit of the Amplicor HCV Monitor Test.
To identify which of the three clones was infectious in
vivo we amplified the NS3 region (nt 3659–4110) from the
chimpanzee serum in a highly sensitive and specific
nested RT–PCR assay with AmpliTaq Gold DNA polymer-
ase and cloned the PCR products with a TA cloning kit
(Invitrogen). In addition, the consensus sequence of the
nearly complete genome (nt 11–9441) was determined by
direct sequencing of overlapping PCR products.
ACKNOWLEDGMENTS
We thank Ms. L. Rasmussen and other staff members at SAIC
(Frederick, MD) for assistance in sequence analysis, staff members at
Bioqual (Rockville, MD) for providing animal care, and Mr. R. Engle at
Georgetown University (Rockville, MD) for performing the second-gen-
eration ELISA and Amplicor HCV Monitor tests. We also thank Mr. C. L.
Apgar for technical assistance. We are grateful to Drs. M. Mayumi, S.
Mishiro, and H. Okamoto for providing plasma containing strain HC-
J4/91 of HCV. This study was supported in part by NIH Contracts
N01-AI-52705, N01-AI-45180, and N01-CO-56000.
Note added in proof. Following submission of this manuscript we
found that chimpanzee 1500 was again positive for HCV RNA during
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